Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Receivables (2018 - 2026)

Wave Life Sciences (WVE) has disclosed Change in Receivables for 8 consecutive years, with -$1.3 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Receivables rose 10.27% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached -$146000.0, up 99.26%, while the annual FY2025 figure was -$146000.0, 99.26% up from the prior year.
  • Change in Receivables hit -$1.3 million in Q1 2026 for Wave Life Sciences, up from -$8.7 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $14.1 million in Q4 2023 and bottomed at -$21.1 million in Q1 2024.
  • Average Change in Receivables over 4 years is $0.0, with a median of $1.3 million recorded in 2024.
  • On a YoY basis, Change in Receivables climbed as much as 749.84% in 2025 and fell as far as 713.5% in 2025.
  • Wave Life Sciences' Change in Receivables stood at $14.1 million in 2023, then tumbled by 89.9% to $1.4 million in 2024, then plummeted by 713.5% to -$8.7 million in 2025, then surged by 85.37% to -$1.3 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$1.3 million, -$8.7 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.